A federal judge trimmed a lawsuit that accuses Sanofi of cornering the market for an injectable form of a diabetes drug, denying the company’s motion to dismiss on all grounds except for a ...

Mylan’s long-running EpiPen scandal has cast a shadow over the company as regulators and politicians have piled on. In an effort to clear the air, Mylan will pay the Securities and Exchange Commission ...

Sanofi has long argued that generics giant Mylan used anticompetitive practices to market its popular epinephrine autoinjector EpiPen, specifically scuppering the launch of its more "consumer-friendly ...

Nov 5 (Reuters) - Generic drugmaker Mylan NV said on Tuesday reevaluation of its portfolio of medicines will continue next year and cautioned of a hit to revenue, and its shares nearly 6%. Mylan, ...

Pharmaceutical firm Mylan is dramatically expanding a nationwide recall of some blood pressure medications after detecting trace amounts of a chemical linked to cancer. The recalled products all ...

The myriad problems with the U.S. healthcare system aren’t the fault of any one person. But every so often, an industry executive spouts something so wrong-headed, it shines a helpful light on what we ...

PITTSBURGH (KDKA/AP) -- Pfizer is buying Mylan in an all-stock deal and combining the $10 billion generic pharmaceutical company with its own off-patent branded and generic business. The Pfizer ...